Quick Links

Technologies for Licensing

McGill University has a rich history of scholarship and strong tradition of cutting edge research and innovation. McGill strives to translate the outcomes of its research endeavors in ways that have regional, national and global impact. McGill University maintains a comprehensive intellectual property portfolio.

You can view a selection of technologies that are available for licensing below:


   Plant Variety

            Currently not available



   Diagnostics and Instrumentation

            Screening assay for agents that induce Langerhans islet neogenesis in vitro (02198)
            Anatomical MRI Analysis Software for early detection and classification Neurological Diseases (04062)
            Maleimide-Terminated Water Soluble Monolayer-Protected-Gold-Nanoparticle (11040)
            Ultrasound System and methods for quantifying analytes and point of care diagnostics (06080)
            Ultrasound System for measuring pH and point of care parameters (09077)
            Rapid Malaria Detection (07116)
            Automatic identification and classification of Vestibulo-Ocular Responses (11045)
            Polymeric Systems for Signal Amplification in Gene Detection (05094)
            Microfluidic microarray for multiplex analysis of biomolecules (07084)



Mechanical and Materials

Network Communications

Thereapeutic Agents


            Cleaved Link N Usage for intervertebral disc repair(13081)
            Multitargeted kinase inhibitors that inhibit breast cancer progression (08082)
            Identification of Peptide Sequences inducing Steroid Production (14007)
            Anti-Mitotic Peptides for Treatment of Glioma (04086)
            Cell permeable Peptide for Allergic Airway Diseases and Viral Infections (05003_13085)
            Peptides to Modulate Cadherin Function (05012)
            TLR4 Modulator for Treatment of Drug Addiction (14096)
            DRR antisense reduces glioma invasiveness (10097)
            Antisense-based small RNA agents targeting GAG of HIV RNA (14064)

            Netrin Derivatives for inhibiting metastasis and neovascularization (10006)
            Nucleic acid hairpins as inhibitors of HIV RNAse H (03050)
            Vaccine Adjuvant Platform (10084) 
           Single chain antibodies directed to pancreatic β cells (11021)

   Chemical Entities

            Hippuristanol and derivatives as Adjuvants in Chemotherapy (05082)
            Inhibitors of human Farnesyl Pyrophosphate Synthase (10114)
            Multi-targeted kinase inhibitors that inhibit breast cancer progression (08082)
            Inhibitors of aminoglycoside acetyltransferases to mitigate resistance to aminoglycoside antibiotics (05040)
            Second generation Inhibitors of 6’-N-aminoglycoside acetyltransferasesas as chemosensitizers of aminoglycoside resistant strains (10082)
            Novel topical treatment for pain (10029)
            Novel treatment for neural diseases and conditions (08049)
            Inhibition of MTHFR (methylenetetrahydrofolate reductase) for cancer therapy (11017)
            Treatment with Acetylsalicylic Acid Prevents Short-to-Mid Term Radiographic Progression of Non-Traumatic Osteonecrosis of the Femoral Head (14071)

   Drug Delivery